Financial reports
10-Q
2024 Q2
Quarterly report
15 Apr 24
10-Q
2024 Q1
Quarterly report
22 Jan 24
NT 10-Q
Notice of late quarterly filing
16 Jan 24
10-K
2023 FY
Annual report
14 Dec 23
NT 10-K
Notice of late annual filing
29 Nov 23
10-Q
2023 Q3
Quarterly report
17 Jul 23
10-Q
2023 Q2
Quarterly report
26 May 23
10-Q
2023 Q1
Quarterly report
24 May 23
NT 10-Q
Notice of late quarterly filing
14 Apr 23
10-K
2022 FY
Annual report
3 Apr 23
Current reports
8-K
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
15 Apr 24
8-K
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
11 Apr 24
8-K
Unregistered Sales of Equity Securities
10 Apr 24
8-K
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
26 Mar 24
8-K
Entry into a Material Definitive Agreement
19 Mar 24
8-K
Entry into a Material Definitive Agreement
18 Mar 24
8-K
Regulation FD Disclosure
21 Feb 24
8-K
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
20 Feb 24
8-K
Novo Integrated Sciences Appoints New President
16 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Feb 24
Registration and prospectus
424B4
Prospectus supplement with pricing info
14 Oct 22
S-1/A
IPO registration (amended)
7 Oct 22
S-1/A
IPO registration (amended)
4 Oct 22
S-1
IPO registration
13 Sep 22
424B3
Prospectus supplement
29 Apr 22
S-3
Shelf registration
18 Apr 22
424B5
Prospectus supplement for primary offering
14 Dec 21
S-3
Shelf registration
8 Jun 21
424B5
Prospectus supplement for primary offering
9 Apr 21
S-3/A
Shelf registration (amended)
19 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
27 Sep 23
DEFA14A
Additional proxy soliciting materials
21 Sep 23
DEFA14A
Additional proxy soliciting materials
18 Aug 23
DEF 14A
Definitive proxy
18 Aug 23
PRE 14A
Preliminary proxy
26 Jul 23
DEF 14C
Information statement
4 Jan 23
PRE 14C
Preliminary information
12 Dec 22
DEFA14A
Additional proxy soliciting materials
4 Aug 22
DEF 14A
Definitive proxy
8 Jul 22
DEF 14C
Information statement
28 Jan 22
Other
EFFECT
Notice of effectiveness
14 Oct 22
CORRESP
Correspondence with SEC
7 Oct 22
CORRESP
Correspondence with SEC
7 Oct 22
UPLOAD
Letter from SEC
14 Sep 22
EFFECT
Notice of effectiveness
28 Apr 22
CORRESP
Correspondence with SEC
26 Apr 22
UPLOAD
Letter from SEC
26 Apr 22
EFFECT
Notice of effectiveness
16 Jun 21
CORRESP
Correspondence with SEC
11 Jun 21
UPLOAD
Letter from SEC
11 Jun 21
Ownership
SC 13G/A
Hudson Bay Capital Management LP
6 Feb 24
4
Christopher Mehlin David
2 Jun 23
SC 13G/A
Hudson Bay Capital Management LP
10 Feb 23
4
Sarfaraz Ali
10 Aug 22
3
Sarfaraz Ali
10 Aug 22
4
Robert Letterio Oliva
21 Apr 22
4
Robert Letterio Oliva
24 Feb 22
4
Alex Flesias
24 Feb 22
4
Michael Ross Pope
24 Feb 22
SC 13G
Hudson Bay Capital Management LP
8 Feb 22